Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction
- PMID: 11229449
Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction
Abstract
Background: Antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), venlafaxine, and clomipramine, are frequently associated with sexual dysfunction. Other antidepressants (nefazodone, mirtazapine, bupropion, amineptine, and moclobemide) with different mechanisms of action seem to have fewer sexual side effects. The incidence of sexual dysfunction is underestimated, and the use of a specific questionnaire is needed.
Method: The authors analyzed the incidence of antidepressant-related sexual dysfunction in a multicenter, prospective, open-label study carried out by the Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. The group collected data from April 1995 to February 2000 on patients with previously normal sexual function who were being treated with antidepressants alone or antidepressants plus benzodiazepines. One thousand twenty-two outpatients (610 women, 412 men; mean age = 39.8 +/- 11.3 years) were interviewed using the Psychotropic-Related Sexual Dysfunction Questionnaire, which includes questions about libido, orgasm, ejaculation, erectile function, and general sexual satisfaction.
Results: The overall incidence of sexual dysfunction was 59.1% (604/1022) when all antidepressants were considered as a whole. There were relevant differences when the incidence of any type of sexual dysfunction was compared among different drugs: fluoxetine, 57.7% (161/279); sertraline, 62.9% (100/159); fluvoxamine, 62.3% (48/77); paroxetine, 70.7% (147/208); citalopram, 72.7% (48/66); venlafaxine, 67.3% (37/55); mirtazapine, 24.4% (12/49); nefazodone, 8% (4/50); amineptine, 6.9% (2/29); and moclobemide, 3.9% (1/26). Men had a higher frequency of sexual dysfunction (62.4%) than women (56.9%), although women had higher severity. About 40% of patients showed low tolerance of their sexual dysfunction.
Conclusion: The incidence of sexual dysfunction with SSRIs and venlafaxine is high, ranging from 58% to 73%, as compared with serotonin-2 (5-HT2) blockers (nefazodone and mirtazapine), moclobemide, and amineptine.
Comment in
-
Role of receptor binding profiles in antidepressant-induced sexual dysfunction.J Clin Psychiatry. 2002 Feb;63(2):168. doi: 10.4088/jcp.v63n0213e. J Clin Psychiatry. 2002. PMID: 11874223 No abstract available.
Similar articles
-
Sexual dysfunction during antidepressant treatment.J Clin Psychiatry. 1993 Jun;54(6):209-12. J Clin Psychiatry. 1993. PMID: 8331089
-
Major depressive disorder, antidepressants, and sexual dysfunction.J Clin Psychiatry. 2006;67 Suppl 6:33-7. J Clin Psychiatry. 2006. PMID: 16848675 Review.
-
Care of the sexually active depressed patient.J Clin Psychiatry. 1999;60 Suppl 17:32-5; discussion 46-8. J Clin Psychiatry. 1999. PMID: 10446740 Review.
-
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.J Clin Psychopharmacol. 2009 Jun;29(3):259-66. doi: 10.1097/JCP.0b013e3181a5233f. J Clin Psychopharmacol. 2009. PMID: 19440080 Review.
-
Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.J Psychiatry Neurosci. 1999 Jan;24(1):45-50. J Psychiatry Neurosci. 1999. PMID: 9987207 Free PMC article.
Cited by
-
Effects of Pharmaceutical Substances with Obesogenic Activity on Male Reproductive Health.Int J Mol Sci. 2024 Feb 15;25(4):2324. doi: 10.3390/ijms25042324. Int J Mol Sci. 2024. PMID: 38397000 Free PMC article. Review.
-
Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study.J Clin Med. 2024 Jan 18;13(2):546. doi: 10.3390/jcm13020546. J Clin Med. 2024. PMID: 38256680 Free PMC article.
-
Efficacy of Various Treatment in Premature Ejaculation: Systematic Review and Network Meta-Analysis.World J Mens Health. 2024 Apr;42(2):338-346. doi: 10.5534/wjmh.230030. Epub 2023 Aug 9. World J Mens Health. 2024. PMID: 37635338 Free PMC article.
-
Sexual characteristics of patients with prostate cancer seen for radiation treatment.Ecancermedicalscience. 2023 Jul 20;17:1577. doi: 10.3332/ecancer.2023.1577. eCollection 2023. Ecancermedicalscience. 2023. PMID: 37533949 Free PMC article.
-
Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder.Front Psychiatry. 2023 Apr 20;14:1115008. doi: 10.3389/fpsyt.2023.1115008. eCollection 2023. Front Psychiatry. 2023. PMID: 37151978 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous